You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

List of Excipients in Branded Drug UNISOM SLEEPTABS


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing UNISOM SLEEPTABS

Excipient Strategy and Commercial Opportunities for UNISOM SLEEPTABS

Last updated: February 25, 2026

What are the key excipient considerations for UNISOM SLEEPTABS?

UNISOM SLEEPTABS, an over-the-counter sleep aid, primarily contains diphenhydramine hydrochloride. Its excipient profile influences product stability, patient acceptance, manufacturing process, and regulatory compliance.

Core excipient components:

  • Binders: Microcrystalline cellulose—used for tablet cohesion.
  • Fillers: Lactose monohydrate—improves tablet volume and flow.
  • Disintegrants: Corn starch—facilitates rapid dissolution.
  • Lubricants: Magnesium stearate—reduces friction during compression.
  • Colors and flavors: FD&C dyes and vanilla flavor—enhance consumer appeal.

Considerations for excipient selection:

  • Patient safety: Lactose may be unsuitable for lactose-intolerant populations.
  • Dissolution profile: Rapid disintegration is essential for fast onset.
  • Stability: Excipients should not interact with the active ingredient or degrade over shelf life.
  • Regulatory compliance: Use of excipients must align with FDA and international guidelines, including permissible colorant levels.

How does excipient choice influence manufacturing and supply chain?

The selection of excipients impacts production efficiency, costs, and scalability:

  • Availability: Microcrystalline cellulose and lactose are globally sourced, reducing supply risk.
  • Cost-effectiveness: Locally available excipients minimize logistics costs.
  • Processing characteristics: Compatibility with existing machinery simplifies scale-up.

What are the commercial opportunities linked to excipient innovation?

Innovating excipient formulations can unlock market growth and competitive advantages:

  • "Clean label" formulations: Removing unnecessary additives appeals to health-conscious consumers.
  • Allergen-free options: Utilizing plant-based or hypoallergenic excipients broadens market reach.
  • Enhanced stability: Incorporating advanced excipients extends shelf life, reducing waste.
  • Taste-masking technologies: Improving palatability increases adherence among young or sensitive populations.

Regulatory and market implications:

  • Patent extensions: Novel excipient combinations or formulations can be protected, extending product lifecycle.
  • Market differentiation: Clear label declarations (e.g., non-GMO, gluten-free) serve as differentiators.
  • Global expansion: Compliance with regional regulatory standards allows entry into emerging markets.

What are prevailing industry trends relevant to excipient strategy?

  • Shift toward natural excipients: Consumers demand cleaner ingredients. Examples include vegetable-based binders and non-GMO starches.
  • Reduced excipient load: Miniaturized, fast-dissolving tablets require minimal excipients.
  • Biodegradable and sustainable excipients: Environmental concerns prompt the use of eco-friendly ingredients.
  • Personalized formulations: Custom excipient mixes tailored to specific demographic needs.

How do regulatory policies shape excipient strategy?

Regulatory frameworks influence excipient approval and labeling:

  • FDA's Inactive Ingredients Database: Ensures excipient safety and permissible concentrations.
  • EU Regulations (EMA): Require detailed excipient documentation for novel or scarce ingredients.
  • International harmonization efforts: Facilitate global market access but demand compliance with multiple standards.

What is the outlook on commercial opportunities?

  • The global sleep aids market, valued at approximately USD 75 billion in 2022, is projected to grow at a CAGR of 6% through 2030.[1]
  • Innovation in excipient profiles can differentiate UNISOM SLEEPTABS in saturated markets.
  • Focus on patient-centric formulations, such as allergen-free and low excipient content, can expand the target demographic.

Key Takeaways

  • Excipient strategy for UNISOM SLEEPTABS centers on optimizing stability, dissolution, safety, and regulatory compliance.
  • Innovation in excipients offers pathways to product differentiation, extended patent life, and expanded market reach.
  • Regulatory policies guide excipient selection but also create opportunities for novel, compliant formulations.
  • Industry trends favor natural, sustainable, and patentable excipients.
  • Market growth in sleep aids supports investment in excipient development to maintain competitive advantage.

FAQs

1. Can excipient modifications affect the efficacy of UNISOM SLEEPTABS?
Yes. Changes in excipients can influence disintegration and dissolution, impacting the onset of sleep aid effects.

2. Are there opportunities to replace lactose in UNISOM SLEEPTABS formulations?
Yes. Alternatives include corn starch or plant-based starches, especially to meet lactose intolerance concerns.

3. How does excipient innovation impact regulatory approval?
Novel excipients or formulations require rigorous safety and stability testing, potentially delaying approval but offering protection via patents.

4. What excipients are emerging in sleep aid formulations?
Plant-based binders, biodegradable disintegrants, and natural flavor additives are increasingly used to align with consumer preferences.

5. How significant is market demand for allergen-free or natural excipient formulations?
It is substantial. Consumers increasingly favor products with transparent ingredient lists and allergen-free options, providing opportunities for differentiation.

References

[1] Grand View Research. (2023). Sleep aids market size, share & trends analysis. https://www.grandviewresearch.com/industry-analysis/sleep-aids-market

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.